Skip to main content Accessibility help
×
Hostname: page-component-84b7d79bbc-2l2gl Total loading time: 0 Render date: 2024-07-28T16:38:42.903Z Has data issue: false hasContentIssue false

3 - Drug action

Published online by Cambridge University Press:  01 June 2010

Tom E. Peck
Affiliation:
Royal Hampshire County Hospital, Winchester
Sue Hill
Affiliation:
Southampton University Hospital
Tom Peck
Affiliation:
Consultant Anaesthetist, Royal Hampshire County Hospital, Winchester
Mark Williams
Affiliation:
Consultant Anaesthetist, Royal Perth Hospital, Australia
Get access

Summary

Mechanisms of drug action

Drugs may act in a number of ways to exert their effect. These range from relatively simple non-specific actions that depend on the physicochemical properties of a drug to highly specific and stereoselective actions on proteins in the body, namely enzymes, voltage-gated ion channels and receptors.

Actions dependent on chemical properties

The antacids exert their effect by neutralizing gastric acid. The chelating agents are used to reduce the concentration of certain metallic ions within the body. Dicobalt edetate chelates cyanide ions and may be used in cyanide poisoning or following a potentially toxic dose of sodium nitroprusside. The new reversal agent, γ-cyclodextrin, selectively chelates rocuronium and reversal is possible from deeper levels of block than can be effected with the anticholinesterases.

Enzymes

Enzymes are biological catalysts, and most drugs that interact with enzymes are inhibitors. The results are twofold: the concentration of the substrate normally metabolized by the enzyme is increased and that of the product(s) of the reaction is decreased. Enzyme inhibition may be competitive (edrophonium for anticholinesterase), non-competitive or irreversible (aspirin for cyclo-oxygenase and omeprazole for the Na+/H+ATPase). Angiotensin-converting enzyme (ACE) inhibitors such as captopril prevent the conversion of angiotensin I to II and bradykinin to various inactive fragments. Although reduced levels of angiotensin II are responsible for the therapeutic effects when used in hypertension and heart failure, raised levels of bradykinin may cause an intractable cough.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Drug action
    • By Tom Peck, Consultant Anaesthetist, Royal Hampshire County Hospital, Winchester, Mark Williams, Consultant Anaesthetist, Royal Perth Hospital, Australia
  • Tom E. Peck, Sue Hill
  • Book: Pharmacology for Anaesthesia and Intensive Care
  • Online publication: 01 June 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511722172.005
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Drug action
    • By Tom Peck, Consultant Anaesthetist, Royal Hampshire County Hospital, Winchester, Mark Williams, Consultant Anaesthetist, Royal Perth Hospital, Australia
  • Tom E. Peck, Sue Hill
  • Book: Pharmacology for Anaesthesia and Intensive Care
  • Online publication: 01 June 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511722172.005
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Drug action
    • By Tom Peck, Consultant Anaesthetist, Royal Hampshire County Hospital, Winchester, Mark Williams, Consultant Anaesthetist, Royal Perth Hospital, Australia
  • Tom E. Peck, Sue Hill
  • Book: Pharmacology for Anaesthesia and Intensive Care
  • Online publication: 01 June 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511722172.005
Available formats
×